What Changed at Ceribell

Every material change AI Health Index has tracked at Ceribell: new modules, model and architecture updates, clinical evidence, regulatory status, security certifications, and integration depth. Each entry states what changed, cites its source, and carries our read on what it means for a buyer. The graded assessment of this vendor across all fifteen capability axes sits on its index profile.

Funding rounds, valuations, and awards are not product changes and are not logged here. Acquisitions appear only where there is direct product impact.

Follow this change log by RSS

Free for your reader, newsletter or automation tool. One feed covers the whole index, and every category has its own.

All feeds and terms

Impact

Type

1 entry

Showing changes for Ceribell only.Show the full log

September 2026

C

Ceribell

Sep 30, 2026

MediumVerified

Regulatory / FDA

Ceribell received FDA 510(k) clearance (K261712) for software that adds Alpha Delta Ratio and Relative Alpha trending, burst suppression monitoring and amplitude integrated EEG to its point of care EEG system. The clearance carries no age restriction, so the same trends apply from premature newborns in the NICU to adults in the ICU and emergency department. Ceribell expects to deliver the features through an automatic software update in the first half of 2027.

Our read

One system across neonatal and adult critical care simplifies training and purchasing for hospitals that run both. The features are cleared but not yet shipping, so they belong in 2027 plans rather than this year's.

Related axis: FDA and Regulatory StatusVendor announcementView source